| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.21B | 6.17B | 5.47B | 5.76B | 5.22B | 5.12B |
| Gross Profit | 2.49B | 2.62B | 2.22B | 1.66B | 1.37B | 1.66B |
| EBITDA | 7.73B | 13.37B | 4.94B | 5.30B | 9.90B | 730.00M |
| Net Income | 12.47B | 12.37B | 6.61B | 10.11B | 18.73B | 7.45B |
Balance Sheet | ||||||
| Total Assets | 72.59B | 72.59B | 61.82B | 65.08B | 71.34B | 55.73B |
| Cash, Cash Equivalents and Short-Term Investments | 18.90B | 18.90B | 18.99B | 20.87B | 13.57B | 6.03B |
| Total Debt | 16.45B | 16.45B | 16.24B | 16.91B | 17.16B | 9.12B |
| Total Liabilities | 21.46B | 21.46B | 20.53B | 20.45B | 20.82B | 12.54B |
| Stockholders Equity | 51.05B | 51.05B | 41.26B | 44.59B | 50.42B | 43.07B |
Cash Flow | ||||||
| Free Cash Flow | 1.86B | 1.81B | 978.00M | -349.00M | -817.00M | 54.00M |
| Operating Cash Flow | 1.95B | 1.92B | 1.04B | -120.00M | -605.00M | 159.00M |
| Investing Cash Flow | 12.02B | 11.88B | 209.00M | 12.64B | 4.39B | -3.22B |
| Financing Cash Flow | -8.84B | -8.74B | -8.12B | -12.45B | 2.40B | 2.45B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $151.44B | 13.47 | 27.01% | 0.11% | 12.49% | 99.03% | |
78 Outperform | $23.10B | 12.14 | 48.08% | ― | 17.00% | 901.05% | |
78 Outperform | $110.28B | 143.62 | 9.71% | ― | 23.78% | ― | |
75 Outperform | $32.53B | 24.79 | 14.07% | 0.79% | 10.66% | 84.89% | |
75 Outperform | $40.09B | 180.81 | 10.11% | ― | 69.97% | ― | |
67 Neutral | $41.70B | 11.27 | 10.33% | ― | -1.32% | 42.56% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% |